Clinical trial
Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin…
NCT00174304 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00174304 |
|---|---|
| Title | Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. |
| Official title | An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine/Atorvastatin Combination In Subjects With Hypertension And Dyslipidaemia. (The JEWEL II Study) |
| Acronym | JEWEL II |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Amlodipine/atorvastatin single pill |
| Enrollment | 1,120 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 27, 2021 |
| Countries | Austria, Belgium, Finland, Greece, Hungary, Ireland, Italy, Portugal, Slovenia, Spain, Switzerland |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: